adapthealth corp. - AHCO

AHCO

Close Chg Chg %
10.27 0.03 0.29%

Open Market

10.30

+0.03 (0.29%)

Volume: 251.44K

Last Updated:

Dec 16, 2025, 1:17 PM EDT

Company Overview: adapthealth corp. - AHCO

AHCO Key Data

Open

$10.25

Day Range

10.15 - 10.44

52 Week Range

7.11 - 11.63

Market Cap

$1.39B

Shares Outstanding

135.42M

Public Float

89.12M

Beta

1.77

Rev. Per Employee

N/A

P/E Ratio

19.08

EPS

$0.55

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.08M

 

AHCO Performance

1 Week
 
-1.25%
 
1 Month
 
11.75%
 
3 Months
 
15.52%
 
1 Year
 
-0.10%
 
5 Years
 
-72.44%
 

AHCO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About adapthealth corp. - AHCO

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Conshohocken, PA.

AHCO At a Glance

AdaptHealth Corp.
555 East North Lane
Conshohocken, Pennsylvania 19428
Phone 1-610-424-4515 Revenue 3.26B
Industry Finance/Rental/Leasing Net Income 82.75M
Sector Finance 2024 Sales Growth 1.9%
Fiscal Year-end 12 / 2025 Employees 10,500
View SEC Filings

AHCO Valuation

P/E Current 19.079
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 15.594
Price to Sales Ratio 0.396
Price to Book Ratio 0.816
Price to Cash Flow Ratio 2.38
Enterprise Value to EBITDA 4.714
Enterprise Value to Sales 1.017
Total Debt to Enterprise Value 0.642

AHCO Efficiency

Revenue/Employee 310,569.048
Income Per Employee 7,880.667
Receivables Turnover 7.992
Total Asset Turnover 0.709

AHCO Liquidity

Current Ratio 1.333
Quick Ratio 1.086
Cash Ratio 0.194

AHCO Profitability

Gross Margin 19.505
Operating Margin 9.034
Pretax Margin 4.171
Net Margin 2.537
Return on Assets 1.799
Return on Equity 5.463
Return on Total Capital 2.236
Return on Invested Capital 2.266

AHCO Capital Structure

Total Debt to Total Equity 135.591
Total Debt to Total Capital 57.554
Total Debt to Total Assets 46.537
Long-Term Debt to Equity 131.74
Long-Term Debt to Total Capital 55.919
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Adapthealth Corp. - AHCO

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.45B 2.97B 3.20B 3.26B
Sales Growth
+132.35% +21.02% +7.73% +1.90%
Cost of Goods Sold (COGS) incl D&A
2.07B 2.62B 2.78B 2.62B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
333.18M 423.44M 420.59M 409.28M
Depreciation
286.68M 383.44M 387.99M 386.98M
Amortization of Intangibles
46.50M 40.00M 32.60M 22.30M
COGS Growth
+128.89% +26.48% +6.10% -5.50%
Gross Income
384.54M 352.54M 422.48M 636.05M
Gross Income Growth
+152.96% -8.32% +19.84% +50.55%
Gross Profit Margin
+15.67% +11.87% +13.20% +19.50%
2021 2022 2023 2024 5-year trend
SG&A Expense
116.03M 156.12M 182.03M 341.44M
Research & Development
- - - -
-
Other SG&A
116.03M 156.12M 182.03M 341.44M
SGA Growth
+84.82% +34.55% +16.60% +87.57%
Other Operating Expense
- - - -
-
Unusual Expense
(19.48M) (11.15M) 851.00M 41.27M
EBIT after Unusual Expense
287.99M 207.57M (610.56M) 253.34M
Non Operating Income/Expense
(1.83M) (253.00K) 18.87M 9.74M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - 100.00K
-
Interest Expense
95.19M 109.41M 132.10M 127.07M
Interest Expense Growth
+129.77% +14.94% +20.73% -3.81%
Gross Interest Expense
95.19M 109.41M 132.10M 127.07M
Interest Capitalized
- - - -
-
Pretax Income
190.96M 97.90M (723.78M) 136.02M
Pretax Income Growth
+192.68% -48.73% -839.29% +118.79%
Pretax Margin
+7.78% +3.30% -22.62% +4.17%
Income Tax
32.81M 24.77M (49.00M) 41.24M
Income Tax - Current - Domestic
10.43M (197.00K) 13.59M 9.19M
Income Tax - Current - Foreign
- - - 6.93M
-
Income Tax - Deferred - Domestic
22.38M 12.21M (62.59M) 32.05M
Income Tax - Deferred - Foreign
- - - 5.83M
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - 100.00K
-
Other After Tax Income (Expense)
- - - (7.67M)
-
Consolidated Net Income
158.15M 73.13M (674.78M) 87.11M
Minority Interest Expense
1.98M 3.82M 4.12M 4.36M
Net Income
156.18M 69.32M (678.89M) 82.75M
Net Income Growth
+196.62% -55.62% -1,079.42% +112.19%
Net Margin Growth
+6.36% +2.33% -21.21% +2.54%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
156.18M 69.32M (678.89M) 82.75M
Preferred Dividends
- - - -
-
Net Income Available to Common
156.18M 69.32M (678.89M) 82.75M
EPS (Basic)
1.2365 0.5166 -5.0605 0.6186
EPS (Basic) Growth
+140.15% -58.22% -1,079.58% +112.22%
Basic Shares Outstanding
126.31M 134.18M 134.16M 133.76M
EPS (Diluted)
1.174 0.4987 -5.0605 0.6105
EPS (Diluted) Growth
+138.12% -57.52% -1,114.74% +112.06%
Diluted Shares Outstanding
133.03M 138.99M 134.42M 135.53M
EBITDA
601.68M 619.86M 661.04M 703.89M
EBITDA Growth
+250.46% +3.02% +6.64% +6.48%
EBITDA Margin
+24.51% +20.87% +20.66% +21.59%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 13.00
Number of Ratings 8 Current Quarters Estimate 0.36
FY Report Date 12 / 2025 Current Year's Estimate 0.70
Last Quarter’s Earnings 0.237 Median PE on CY Estimate N/A
Year Ago Earnings 1.062 Next Fiscal Year Estimate 1.003
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 7 8 8
Mean Estimate 0.36 0.05 0.70 1.00
High Estimates 0.50 0.15 0.78 1.23
Low Estimate 0.30 -0.00 0.58 0.81
Coefficient of Variance 18.37 93.46 9.59 14.41

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 1 1 1
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Adapthealth Corp. in the News